Law Office of Brodsky & Smith, LLC Announces Investigation of Conmed Healthcare Management, Inc.

BALA CYNWYD, Pa.--(BUSINESS WIRE)--

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Conmed Healthcare Management, Inc. (“Conmed” or the “Company”) CONM relating to the proposed acquisition by Ayelet Investments, LLC (“Ayelet”).

Under the terms of the transaction Conmed shareholders would receive cash of $3.85 for each share of Conmed stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Conmed by not acting in the Conmed shareholders' best interests in connection with the sale process to Ayelet. The transaction may undervalue Conmed as Conmed stock traded at $3.95 on June 24, 2011 and an analyst has set a price target of $5.00 for Conmed stock.

If you own shares of Conmed stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com, visiting http://brodsky-smith.com/311-conm-conmed-healthcare-management-inc.html, or by calling toll free 877-LEGAL-90.